Clinical Trials for Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Find clinical trials for blast phase chronic myelogenous leukemia, bcr-abl1 positive. Discover research opportunities and treatment options in your area.

5 Active Trials Found

Showing 5 trials on this page

Page 1 of 1

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

NCT ID: NCT03326921

This clinical trial is testing a new type of immunotherapy called HA-1 T cell therapy to treat patients with certain types of acute leukemia that have come back, are not responding to treatment, or...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States

Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia

NCT ID: NCT03263572

This clinical trial is studying a combination of four medications—blinatumomab, methotrexate, cytarabine, and ponatinib—to see how well they work for patients with Philadelphia chromosome-positive ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers

NCT ID: NCT03589729

This clinical trial is studying a medication called dexrazoxane hydrochloride to see if it can help prevent heart-related side effects that can occur during chemotherapy for blood cancers, such as ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

NCT ID: NCT03630991

This clinical trial is studying two potential treatments, edetate calcium disodium and succimer, for patients with certain types of blood cancers, specifically acute myeloid leukemia (AML) or myelo...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

NCT ID: NCT02115295

This clinical trial is investigating a combination of four chemotherapy drugs—cladribine, idarubicin, cytarabine, and venetoclax—to see how well they work in treating patients with certain types of...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions